Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Aarti Pharmalabs Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543748 border-img ISIN Demat INE0LRU01027 border-img Book Value 210.00 border-img NSE Symbol AARTIPHARM border-img Div & Yield % 0.7 border-img Market Cap (₹ Cr.) 6463.15 border-img P/E 26.44 border-img EPS 26.97 border-img Face Value 5
ParticularsMar 2025
(₹)		Mar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)
INCOME :       
Sales Turnover 1771.351502.131511.25941.020.000.00
Excise Duty 0.000.000.000.000.000.00
Net Sales 1771.351502.131511.25941.020.000.00
Other Income 14.4911.011.282.510.000.00
Stock Adjustments -47.8523.3691.2232.540.000.00
Total Income 1737.991536.501603.75976.070.000.00
EXPENDITURE :       
Raw Materials 831.41775.33909.15484.200.000.00
Power & Fuel Cost 80.1982.9274.2243.430.000.00
Employee Cost 139.82120.15113.9279.980.000.00
Other Manufacturing Expenses 118.83109.2691.11164.690.000.00
Selling & Administrative Expenses 101.2266.5582.9321.460.000.02
Miscellaneous Expenses 25.4925.1322.800.010.000.00
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 1296.951179.331294.14793.780.000.02
Operating Profit 441.03357.16309.62182.300.00-0.02
Interest 25.6316.6320.4911.340.000.00
Gross Profit 415.40340.53289.13170.960.00-0.02
Depreciation 79.0666.0155.7737.230.000.00
Profit Before Tax 336.34274.52233.36133.730.00-0.02
Tax 56.7146.0652.1322.500.000.00
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 22.2827.829.504.500.000.00
Reported Net Profit 257.35200.65171.73106.730.00-0.02
Extraordinary Items 0.000.000.000.030.000.00
Adjusted Net Profit 257.35200.65171.73106.700.00-0.02
Adjustment below Net Profit -1.420.000.00599.240.000.00
P & L Balance brought forward 1042.07859.55705.95-0.02-0.020.00
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 31.7218.1318.130.000.000.00
P & L Balance carried down 1266.281042.07859.55705.95-0.02-0.02
Dividend 0.000.0018.130.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 100.0060.0040.000.000.000.00
Dividend Per Share(Rs) 5.003.002.000.000.000.00
Earnings Per Share-Unit Curr 28.3922.1418.954269.05-0.18-0.75
Earnings Per Share(Adj)-Unit Curr 28.3922.1418.954269.05-0.18-0.75
Book Value-Unit Curr 203.44178.92158.7449558.529.079.25
Book Value(Adj)-Unit Curr 203.44178.92158.7449558.529.079.25

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh